Sell or avoid NKE. The double downgrade from a high-accuracy firm, combined with accelerating negative EPS revisions, heavy insider selling, and extreme short interest, points to further downside. The weak reward profile (7.5% to Truist's PT) versus elevated risk makes this a clear caution signal for active traders.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Aug 26 $38.59entry
- T+1 · 3mo ago −0.39%α −1.04% · $38.44
- T+5 · 3mo ago −0.91%α −0.79% · $38.24
- T+20 · 8w ago −6.74%α −6.88% · $35.99
- T+57 · todayOpen
- T+60 · in 2d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Truist Securities double-downgrades NKE (NIKE, Inc.) from Buy to Hold, slashing the price target to $42 from $47, a 10.6% reduction. The stock trades at $39.06, implying only ~7.5% upside to the new target, well below the consensus mean of $50.52. Truist has a 55% accuracy rate on 3,784 scored calls with a +3.1% average return, slightly above average for firms covering NKE. The consensus is heavily tilted toward Hold: 26 of 46 analysts rate Hold, with 18 Buy-rated (10 strong buy, 8 buy), 2 sell, and 0 strong sell. The 30-day analyst activity shows 2 downgrades (Truist and JP Morgan) and 0 upgrades. EPS revisions are negative, the next-quarter estimate saw 2 downward revisions in 30 days, and the current-year estimate had 7 downward revisions. Insider sales occurred in early August totaling ~$400K, a modest, liquidity-pattern cluster that does not contradict the downgrade's bearishness. Short interest at 58.1% ratio suggests heavy bearish positioning. Bottom line: Truist's well-timed downgrade aligns with deteriorating fundamentals and negative consensus drift, a further negative catalyst for a stock already under pressure.
Impact Score
Consensus & Targets
Consensus stands at 46 total analysts: 18 Buy (10 strong buy, 8 buy), 26 Hold, 2 Sell, 0 strong sell. The Hold-heavy consensus (56.5%) reflects broad skepticism. Truist moving from Buy to Hold further tilts the balance toward caution. No strong sell ratings exist, suggesting the bear case is not fully reflected.
Current price $39.06. Consensus mean $50.52 (median $46.50). High $94, low $23. Truist's $42 is below both mean and median, sitting at the 22nd percentile of the target range. Implied upside to mean is 29.3%, but Truist's target implies only 7.5% reward, a low-risk/reward setup. The prior $47 target was already below consensus.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-26 | Truist Securities | downgrade | Hold | $42.00 |
| 2026-08-25 | RBC Capital | reiterate | Sector Perform | $45.00 |
| 2026-08-04 | JP Morgan | downgrade | Underweight | $40.00 |
| 2026-07-01 | Jefferies | maintain | Buy | $75.00 |
| 2026-07-01 | UBS | maintain | Neutral | $48.00 |
| 2026-07-01 | Telsey Advisory Group | maintain | Market Perform | $47.00 |
| 2026-07-01 | Baird | reiterate | Outperform | No target |
| 2026-07-01 | BNP Paribas | reiterate | Underperform | No target |
| 2026-07-01 | Bernstein | maintain | Outperform | $72.00 |
| 2026-07-01 | Citigroup | maintain | Neutral | $45.00 |
30-day analyst activity: 2 downgrades (Truist and JP Morgan), 0 upgrades. The last 30 days saw zero upgrades. EPS estimate revisions are negative: +1 quarter saw 2 downward revisions in 30 days; current-year estimates had 7 downward revisions. Near-term (next quarter) estimates were actually revised up by 1 in the last 7 days, but the broader trend is bearish.
Firm Track Record: Truist Securities
Truist Securities accuracy: 55% on 3784 calls | avg return: 3.1%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Wedbush | 67% | 2/3 | 0.2% | top tier |
| TD Cowen | 60% | 3/5 | 2.5% | above average |
| Williams Trading | 50% | 2/4 | 8.9% | below average |
| Goldman Sachs | 50% | 2/4 | 10.1% | below average |
| Keybanc | 50% | 1/2 | 2.3% | below average |
| Oppenheimer | 50% | 1/2 | 4.3% | below average |
| Citigroup | 43% | 3/7 | 2.2% | below average |
| RBC Capital | 38% | 3/8 | -1.2% | below average |
| Evercore ISI Group | 33% | 2/6 | 0.7% | below average |
| BMO Capital | 33% | 1/3 | -5.1% | below average |
Truist Securities has a 55% accuracy rate on 3,784 scored calls with an average return of +3.1%, placing it above the coverage universe average. Among firms tracking NKE, Wedbush (67% on 3 calls) and TD Cowen (60% on 5 calls) have better accuracy. Truist's track record is solid enough to lend credibility to this double downgrade, notably above low-accuracy firms like BofA (22%) and Telsey (22%).
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1q | $0.53 | $0.46 to $0.58 | $11.9B | ↑0 ↓0 |
| +1y | $2.23 | $1.50 to $4.00 | $47.5B | ↑0 ↓0 |
| 0q | $0.45 | $0.42 to $0.50 | $11.4B | ↑1 ↓0 |
| 0y | $1.72 | $1.51 to $1.96 | $45.7B | ↑0 ↓0 |
Cross-Platform Signals
Insider trades: 5 sales totaling ~$400K, clustered around August 5-7, 2026, including CFO Montagne Amy ($204K) and EVP Friend Matthew ($102K). These are modest, non-patterned sales that weakly confirm the bearish signal. Short interest of 58.1% ratio (11.4M shares short against 19.6M TRF volume) points to extreme bearish positioning. Congressional activity: Rep. Ro Khanna (D-CA) bought $1K-$15K of NKE on July 7, a trivial, likely unrelated personal trade. Institutional flow is mixed: Amundi added 59.4% ($265mm) while HighTower near-exited (-81.1%). The insider selling and extreme short interest strongly converge with the analyst downgrade's negative narrative.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
33 reports on NKE
7 of 9 bullish or bearish reports moved the stock their way by T+60. Best: +26.31% at T+60 after the Feb 28, 2026 report. 10 of 12 went positive at some point.
Filters
- Nov 13, 20263d ago 3 Neutral 1/10 Entry $37.91 Now $38.26 +0.92% settles Feb 12
- Nov 10, 20266d ago ANALYST-UPGRADE Neutral 1/10 Entry $38.67 Now $38.26 −1.06% settles Feb 8
- Nov 9, 20267d ago 8-K Neutral 2/10 Entry $38.67 Now $38.26 −1.06% settles Feb 8
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $38.67 Now $38.26 −1.06% settles Jan 28
- Oct 20, 202627d ago Institutional Cluster Mixed 3/10 Entry $37.53 Now $38.26 +1.95% settles Jan 19
- Oct 2, 20266w ago ANALYST-UPGRADE Bullish 4/10 Entry $33.96 Now $38.26 +12.66% settles Dec 30
- Sep 25, 20267w ago ANALYST-DOWNGRADE Bearish 4/10 No price data
- Sep 22, 20267w ago ANALYST-UPGRADE Neutral 1/10 Entry $36.10 Now $38.26 +5.98% settles Dec 16
- Sep 14, 20269w ago ANALYST-DOWNGRADE Bearish 5/10 Entry $37.05 Now $38.26 −3.27% settles Dec 8
- Sep 10, 20269w ago Insider Cluster Neutral 3/10 Entry $36.80 Now $38.26 +3.97% settles Dec 7
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers